Concurrent use may potentiate CNS adverse reactions and increase risk of intestinal obstruction and urinary retention. More frequent monitoring recommended.
Source: NLP:scopolamine
2 interactions on record
Concurrent use may potentiate CNS adverse reactions and increase risk of intestinal obstruction and urinary retention. More frequent monitoring recommended.
Source: NLP:scopolamine
Concurrent use may potentiate CNS adverse reactions and anticholinergic effects. Monitor for increased risk of intestinal obstruction and urinary retention.
Source: NLP:scolopamine transdermal system